H35.52 Pigmentary retinal dystrophy

Name of the Condition

• Pigmentary Retinal Dystrophy
• Also known as Retinitis Pigmentosa (RP) or H35.52 in the ICD coding system.

Summary

Pigmentary retinal dystrophy, commonly referred to as Retinitis Pigmentosa, is a group of genetic disorders characterized by the progressive degeneration of the retina, leading to a gradual decline in vision.

Causes

• Primarily caused by genetic mutations.
• Can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner.

Risk Factors

• Family history of retinal dystrophies increases the risk.
• Certain genetic mutations are known to cause the condition.

Symptoms

• Night blindness is often the first symptom.
• Loss of peripheral vision, leading to tunnel vision.
• Difficulty adapting to low-light conditions.
• In advanced stages, loss of central vision.

Diagnosis

• Comprehensive eye examination.
• Electroretinography (ERG) to assess the electrical responses of the retina.
• Genetic testing to identify specific mutations.
• Visual field tests.

Treatment Options

• No cure, but management focuses on slowing progression and maximizing remaining vision.
• Vitamin A supplementation may help slow progression in some patients.
• Low vision aids and adaptive devices.
• Gene therapy and retinal implants are emerging treatments under investigation.

Prognosis and Follow-Up

• Vision loss is progressive and varies depending on the specific genetic mutation.
• Regular ophthalmic follow-ups are crucial to monitor changes and adjust management strategies.

Complications

• Significant visual impairment or blindness.
• Possible psychological impact due to declining vision.

Lifestyle & Prevention

• Use of UV-protective sunglasses can help protect residual vision.
• High-dose Vitamin A has shown some benefit in slowing disease progression.
• Genetic counseling is recommended for affected individuals and family planning.

When to Seek Professional Help

• If experiencing symptoms such as night blindness or restriction in field of vision.
• Sudden changes in vision warrant immediate attention.

Additional Resources

• National Eye Institute (NEI)
• Retinitis Pigmentosa International (RPI)
• Foundation Fighting Blindness

Tips for Medical Coders

• Verify if documentation specifies 'Pigmentary Retinal Dystrophy' to apply H35.52 correctly.
• Be aware of synonymous terms like 'Retinitis Pigmentosa.'
• Ensure accuracy by cross-referencing genetic test results, if available, in the patient's medical record.